Loading...
Medetomidine, a potent alpha-2 adrenergic agonist used in veterinary medicine, has emerged as an adulterant in the illicit fentanyl supply. Because this drug’s effects differ from those of opioids alone, clinicians may not recognize medetomidine intoxication and withdrawal. Two recent studies characterize these clinical presentations.
In a retrospective study of opioid overdoses in Chicago in 2024, researchers described clinical outcomes for 12 patients with laboratory-confirmed medetomidine exposure.
All 12 had persistent altered mental status despite naloxone.
Seven required respiratory support, including three who were intubated; five required ICU care.
Among those admitted, median hospital stay was 3.5 days.
In another stud…